Evidence map›Paper›PMID 21191403›Full record

ArticleThe Journal of investigative dermatology2011

Noninvasive in vivo imaging to evaluate immune responses and antimicrobial therapy against Staphylococcus aureus and USA300 MRSA skin infections.

John S Cho, Jamie Zussman, Niles P Donegan, Romela Irene Ramos, Nairy C Garcia, Daniel Z Uslan, Yoichiro Iwakura, Scott I Simon, Ambrose L Cheung, Robert L Modlin and 2 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Longitudinal intravital imaging of the bone marrow for analysis of the race for the surface in a murine osteomyelitis model.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Interleukin-1β and tumor necrosis factor are essential in controlling an experimental orthopedic implant-associated infection.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Clonal Vγ6Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  17. Article
  18. Control ofInfection and immunity · 2019
    Article
  19. Article
  20. Immune and Inflammatory Reponses toCurrent dermatology reports · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

John S ChoDivision of Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Jamie Zussman
Niles P Donegan
Romela Irene Ramos
Nairy C Garcia
Daniel Z Uslan
Yoichiro Iwakura
Scott I Simon
Ambrose L Cheung
Robert L Modlin
Jenny Kim
Lloyd S Miller
University of California, Los Angeles · USDartmouth College · USThe University of Tokyo · JPUniversity of California, Davis · USVA Greater Los Angeles Healthcare System · US

Funding

UCLA Imaging Resource for Mouse Cancer ModelsR24CA092865 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PHELPS, MICHAEL E · 2001 to 2006
$4.3M
The role of GraRS in resistance to cationic antimicrobial peptides in S. aureusR01AI091801 · NIAID · DARTMOUTH COLLEGE · PI CHEUNG, AMBROSE LIN YAU · 2011 to 2015
$2.4M
GRANULYSIN: ANTIMICROBIAL/ANTI-INFLAMMATORY ROLE IN ACNER01AI059091 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODLIN, ROBERT L · 2005 to 2009
$1.8M
Innate Immune Response to Staphylococcus aureus in SkinR01AI078910 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MILLER, LLOYD S · 2009 to 2013
$1.7M
Dermatology Scientist Training ProgramT32AR058921 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODLIN, ROBERT L · 2010 to 2014
$877k
Host defense against Staphylococcus aureus skin infectionsR03AR054534 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MILLER, LLOYD S · 2008 to 2010
$230k
NCI NIH HHS R24 CA092865NCI NIH HHS R24 CA92865NIAID NIH HHS R01 AI059091NIAID NIH HHS R01 AI078910NIAID NIH HHS R01 AI091801NIAMS NIH HHS R03 AR054534NIAMS NIH HHS T32 AR058921
6 · The paper itself

Abstract

Staphylococcus aureus skin infections represent a significant public health threat because of the emergence of antibiotic-resistant strains such as methicillin-resistant S. aureus (MRSA). As greater understanding of protective immune responses and more effective antimicrobial therapies are needed, a S. aureus skin wound infection model was developed in which full-thickness scalpel cuts on the backs of mice were infected with a bioluminescent S. aureus (methicillin sensitive) or USA300 community-acquired MRSA strain and in vivo imaging was used to noninvasively monitor the bacterial burden. In addition, the infection-induced inflammatory response was quantified using in vivo fluorescence imaging of LysEGFP mice. Using this model, we found that both IL-1α and IL-1β contributed to host defense during a wound infection, whereas IL-1β was more critical during an intradermal S. aureus infection. Furthermore, treatment of a USA300 MRSA skin infection with retapamulin ointment resulted in up to 85-fold reduction in bacterial burden and a 53% decrease in infection-induced inflammation. In contrast, mupirocin ointment had minimal clinical activity against this USA300 strain, resulting in only a 2-fold reduction in bacterial burden. Taken together, this S. aureus wound infection model provides a valuable preclinical screening method to investigate cutaneous immune responses and the efficacy of topical antimicrobial therapies.

Indexed as

Staphylococcal Skin InfectionsAdministration, TopicalAnimalsAnti-Bacterial AgentsBridged Bicyclo Compounds, HeterocyclicCommunity-Acquired InfectionsDermatitisDermoscopyDisease Models, AnimalDiterpenesDrug MonitoringGreen Fluorescent ProteinsInterleukin-1alphaInterleukin-1betaMaleMethicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsBridged Bicyclo Compounds, HeterocyclicDiterpenesenhanced green fluorescent proteinGreen Fluorescent ProteinsInterleukin-1alphaInterleukin-1betaMupirocinretapamulin

Identifiers

PMID21191403
PMCPMC3059384
OpenAlexW2055091410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.